Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis
Cysteamine, a drug approved to treat cystinosis, has been proposed as a host-directed therapy for (Mtb) and SARS-CoV-2. The impact of cysteamine on the immune responses has not been fully investigated. We aimed to evaluate the immunomodulatory effects of cysteamine on peripheral blood mononuclear ce...
Saved in:
| Published in: | Frontiers in immunology Vol. 15; p. 1411827 |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Switzerland
Frontiers Media SA
28.10.2024
Frontiers Media S.A |
| Subjects: | |
| ISSN: | 1664-3224, 1664-3224 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!